By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aquinox Pharmaceuticals 

5600 Parkwood Way
Suite 430
Richmond  British Columbia  V6V 2M2  U.S.A.
Phone: 604-629-9223 Fax: 604-295-4748




Company News
Aquinox Pharmaceuticals (AQXP) Announces Third Quarter 2014 Financial Results 11/4/2014 8:21:40 AM
Aquinox Pharmaceuticals (AQXP) Announces Second Quarter 2014 Financial Results 8/11/2014 5:04:30 PM
Aquinox Pharmaceuticals (AQXP) To Present At Canaccord Genuity 34th Annual Growth Conference 8/6/2014 4:35:50 PM
Aquinox Pharmaceuticals (AQXP) To Announce Second Quarter Financial Results And Host Conference Call On August 11, 2014 8/5/2014 3:44:37 PM
Aquinox Pharmaceuticals (AQXP) Announces Expansion Of Ongoing Phase 2 Trials Of AQX-1125, Including Acceptance Of U.S. IND 6/2/2014 9:22:38 AM
Aquinox Pharmaceuticals (AQXP) To Present At Upcoming Investor Conferences 5/21/2014 9:15:30 AM
Aquinox Pharmaceuticals (AQXP) Announces Closing Of Initial Public Offering 3/12/2014 8:32:46 AM
Vancouver's Aquinox Pharmaceuticals (AQXP) Prices Upsized IPO At $11, Raises $46 Million 3/7/2014 9:32:24 AM
Aquinox Pharmaceuticals Completes $18 Million Series C Financing 4/3/2013 7:33:15 AM
Aquinox Pharmaceuticals Receives Regulatory Clearance to Initiate First Clinical Study of AQX-1125, A Novel Oral Anti-Inflammatory Compound 1/5/2011 9:58:36 AM